In this study, we found that ME2 and PRMT1 can interact with each other and that ME2 can promote the proliferation and invasion of HCC cells; however, when arginine 67 is mutated to lysine, the promoting effect of ME2 on HCC cells is reversed. The gene discussed is ME2; the disease is hepatocellular carcinoma.